Permian Research Foundation

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Stroke3 trials
• Atrial fibrillation2 trials
• Chronic kidney disease1 trial
• Coronary artery disease1 trial

Phase

• Phase 22 trials
• Phase 32 trials

Status

• Recruiting2 trials
• Completed1 trial
• Withdrawn1 trial

Lead sponsor

• Regeneron Pharmaceuticals2 trials
• Amgen1 trial
• Eli Lilly and Company1 trial

Running trials

• Recruiting

  Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

  NCT07626411· Phase 3· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Recruiting

  Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

  NCT07175428· Phase 2· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation2 recruiting
• Stroke2 recruiting

Closed trials

• Withdrawn

  Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease

  NCT06598631· Phase 2· Eli Lilly and Company· Source

• Completed

  Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

  NCT03872401· Phase 3· Amgen· Source